FRANKLIN LAKES, N.J., Aug. 27 /PRNewswire-FirstCall/ -- BD (Becton,
Dickinson and Company) (NYSE: BDX), a global medical technology company,
announced today that it would present at the following investor healthcare
Thomas Weisel Healthcare Conference 2008
September 4, 2008
1:30 p.m. EDT
Morgan Stanley Global Healthcare Unplugged Conference
September 9, 2008
8:00 a.m. EDT
A live webcast of BD's presentations can be accessed from the BD corporate website at http://www.bd.com/investors. They will be available for replay for a period of seven days.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
For more information, please visit http://www.bd.com.
|SOURCE BD (Becton, Dickinson and Company)|
Copyright©2008 PR Newswire.
All rights reserved